Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
In TCM, the "Dampness pathogen" (also called "Dampness evil" or "Shi Xie") refers to a conceptual pathogenic influence, not a discrete molecular, protein, or receptor target. It arises from environmental humidity, diet, or dysfunction of organs (especially spleen and stomach) and leads to disruption in the body's fluid transformation and transportation, resulting in symptoms such as feeling of heaviness, sluggishness, abdominal distension, diarrhea, poor appetite, and thick or greasy tongue coating[1][7][9]. TCM views dampness as a yin pathogen that can combine with other influences such as heat (damp-heat), complicating disease patterns[4][10]. "Dampness pathogen" is invoked in TCM explanations of a range of chronic and metabolic diseases, but has no correlating structure in modern molecular or receptor-based medicine. In summary, "Dampness pathogen" is a traditional theoretical construct, not a molecular entity or therapeutic target. The entry is considered incorrect in the context of molecular pharmacology or structured biomedical databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dampness pathogen.